Cliff Asness's SKIN Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 90,017 shares of The Beauty Health Company (SKIN) worth $179,133, representing 0.00% of the portfolio. First purchased in 2023-Q3, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in SKIN, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 35,227 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's The Beauty Health Company (SKIN) Holding Value Over Time
Track share changes against reported price movement
Quarterly The Beauty Health Company (SKIN) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2023 | +11,952 | New Buy | 11,952 | $6.02 |
| Q4 2023 | -11,952 | Sold Out | 11,952 | $6.02 |
| Q1 2025 | +29,972 | New Buy | 29,972 | $1.34 |
| Q2 2025 | +35,227 | Add 117.53% | 65,199 | $1.91 |
| Q3 2025 | +24,818 | Add 38.07% | 90,017 | $1.99 |
Cliff Asness's The Beauty Health Company Investment FAQs
Cliff Asness first purchased The Beauty Health Company (SKIN) in Q3 2023, acquiring 11,952 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held The Beauty Health Company (SKIN) for 9 quarters since Q3 2023.
Cliff Asness's largest addition to The Beauty Health Company (SKIN) was in Q2 2025, adding 65,199 shares worth $124,529.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 90,017 shares of The Beauty Health Company (SKIN), valued at approximately $179,133.
As of the Q3 2025 filing, The Beauty Health Company (SKIN) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in The Beauty Health Company (SKIN) was 90,017 shares, as reported at the end of Q3 2025.